Capital Fund Management S.A. Acquires New Shares in HCA Healthcare, Inc. (NYSE:HCA)

Capital Fund Management S.A. bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 144,236 shares of the company’s stock, valued at approximately $43,292,000. Capital Fund Management S.A. owned about 0.06% of HCA Healthcare at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Whipplewood Advisors LLC bought a new stake in HCA Healthcare in the fourth quarter valued at about $31,000. Tidemark LLC bought a new stake in HCA Healthcare during the fourth quarter worth about $36,000. Activest Wealth Management grew its stake in HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after buying an additional 125 shares during the last quarter. Pinnacle Bancorp Inc. grew its stake in HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after buying an additional 50 shares during the last quarter. Finally, Eastern Bank acquired a new position in shares of HCA Healthcare during the fourth quarter worth approximately $62,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

NYSE HCA opened at $339.10 on Thursday. The firm has a 50-day moving average of $327.56 and a 200-day moving average of $337.50. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The stock has a market cap of $83.49 billion, a PE ratio of 15.43, a P/E/G ratio of 1.10 and a beta of 1.48. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the business posted $5.90 earnings per share. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were issued a $0.72 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.85%. The ex-dividend date of this dividend was Monday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.11%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.30% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on HCA. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. Truist Financial cut their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Morgan Stanley cut their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. StockNews.com downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have assigned a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.